Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial)

American Journal of Cardiology

Volumn 82, Issue 4, 1998, Pages 414-417

  Davey, Peter J ^a   Schulz, Mark ^b   Gliksman, Michael ^b   Dobson, Matthew ^b   Aristides, Michael ^b   Stephens, Nigel G ^b  

^a AKC Consultants Pty Ltd   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMYL NITRATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

ACUTE HEART INFARCTION; ARTICLE; AUSTRALIA; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

AUSTRALIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; COST SAVINGS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; MYOCARDIAL INFARCTION; UNITED STATES; VITAMIN E;

EID: 0031843368     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00354-3     Document Type: Article

References (7)

1. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;247:781-786.
2. Kardinaal AFM, Kok FJ, Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, Riemersma RA, van't Veer P, Huttunen JK, Martin-Moreno JM. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993;342:1379-1384.
3. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-0000.
4. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner R, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-1449.
5. Palmer G, Aisbett C, Fetter R, Winchester L, Reid B, Rigby E. Casemix Costs and Casemix Accounting in 7 Major Sydney Teaching Hospitals. 1st ed. Sydney: Centre for Hospital Management and Information Systems Research, 1991.
6. Davey P, Hall J, Seymor J. Cost-effectiveness of pravastatin for secondary prevention of IHD: feasibility and pilot costing study. Centre for Health Economics Research and Evaluation [discussion paper 17]1993:1-31.
7. Tsevat J, Duke D, Goldman L, Pfeffer M, Lamas G, Soukup J, Kuntz K, Lee T. Cost-effectiveness of captopril therapy after myocardial infarction. J Am Coll Cardiol 1995;26:914-919.